Happening NOW at the UNSW Cancer Symposium in Sydney! 👋 Meet our team and explore how you can take your cancer research to the next level. Reproducibly model the complexities of tumour microenvironment without disruption to your current workflow and access our full range of matrices to suit your cancer cell types #UNSWCancerSymposium2024 #CancerResearch #phenotypicCellmodels #3Dcellmodels #3Dcellculture #immunooncology #tumourmicroenvironment
Inventia Life Science’s Post
More Relevant Posts
-
R&D technical expert | Focus on technical innovation and team management in pharmaceutical R&D, assisting in the development of products from concept to clinical practice
This #BloodCancerAwarenessMonth and #WorldLymphomaAwarenessDay, we’re honoring the progress made in blood cancer research while recognizing there’s still more to be done. Using our deep understanding of cancer biology and cutting-edge technology, we’re facing some of the hardest-to-treat blood cancers head-on, aiming to provide more options to patients in need. #WLAD2024 Learn more about our mission to transform cancer care: https://bit.ly/3T6jFjm
-
Executive Editor - Gold Open Access Journals & Technology in Cancer Research & Treatment (IF 2.7; CiteScore 4.4). PhD in Molecular, Cell & Developmental Biology, UCLA.
In honor of #WorldOvarianCancerDay I am happy to share several of Technology in Cancer Research & Treatment's recent articles that are free to read: https://shorturl.at/hCEKP Technology in Cancer Research & Treatment is a strong supporter of ovarian cancer research. If you are interested in publishing with the journal, you can read more bout the journal here: https://lnkd.in/g3_JFhRc #WOCD24 #OvarianCancerDay #Ovariancancerawareness #OvarianCancer #EndCancer #OncoDaily
-
As the fight against cancer continues to evolve, so does the National Foundation for Cancer Research—adapting to emerging scientific trends and transformative technologies and incorporating state-of-the-art methodologies into its grant programs. Learn more about how NFCR is preparing for the future of cancer research by visiting: https://lnkd.in/guP4TgbB #NFCR #MakeCuresPossible #Cancer #Research #Vision #Future #CancerResearch #Investinginthefuture #annualreport
-
-
❇️ NEOPRISM-CRC is the first multicenter, phase 2 trial to determine the safety and efficacy of neoadjuvant #pembrolizumab when stratified by TMB for high-risk stage II-III #colorectal cancer. ❇️ Learn about the new study data presented at #ASCO24 by Dr. Kai-Keen Shiu of UCL Cancer Institute:
Neoadjuvant Pembrolizumab for Early-Stage dMMR/MSI-High CRC | Docwire News
docwirenews.com
-
Watch the video below and help us share the word! 📢 Count Me In's #Colorectal Cancer Project led by Dr. Kimmie Ng of Dana-Farber Cancer Institute is only possible through direct collaboration with #cancerpatients. Visit https://lnkd.in/efxeGqyp today to learn more about how patients can partner with us to improve research for CRC. #ColorectalCancerAwarenessMonth #Research #HealthEquityNow
-
Very important to sher the knowledge for the patients - go ahead
🚀 Our team present at #WCLC24, organised by International Association for the Study of Lung Cancer, a key event for the advancement of lung cancer research and treatment. This conference brings together leading experts, researchers and oncologists in San Diego to learn about the latest advances in research, treatments and personalised therapies.
-
-
Last week I attended this Innovation Series Seminar! I am really happy for what NUNO Prego Ramos has achieved! Also, this success story is an inspiration for biotech projects from Portugal! The quality of the content was huge, but I will highlight: 1) Aim for something bigger than ourselves; 2) Negative experiences give you lessons to learn; 3) Manage people with transparency. I would say that the key to success is take care of your relationships! #entrepreneurship #innovation #technologytransfer
💡 The first open session of the Innovation Speaker Series with guest speaker NUNO Prego Ramos is this Wednesday, 29 May - Join us! Our guest will share the journey of CellmAbs, from its early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation 🙌 The Innovation Speaker Series was originally designed to introduce the Champalimaud Foundation’s Community on how to bring their research to the marketplace, but this session is open to all. 🎙️ NUNO Prego Ramos, Co-Founder and CEO of CellmAbs 📅 29 May 24 🕒 3pm 📍 Seminar Room, Champalimaud Foundation 🎟️ Free event, but RSVP is required: https://lnkd.in/daEYBGwS #InnovationSpeakerSeries #FreeEvent #BiotechInnovation Nina Patrick, PhD
-
-
On #WorldCancerDay, I acknowledge the crucial role of research in the ongoing battle against cancer. Emphasising the importance of regular screenings and check ups is not just a call for personal well-being, but a collective effort to propel scientific breakthroughs. Let's champion early detection and support ongoing research to make strides in the fight against cancer. #ResearchMatters #EarlyDetection
-
Join us in Bilbao, Spain for Cancer Matabolism to hear from top experts in the field who will discuss the metabolic alterations in tumours and how we can exploit this to treat cancer. There's one month until registration closes: https://lnkd.in/eF3pU7yi
-
-
Explore the results of our new survey, commissioned by the Cancer Research Institute and Regeneron, to see how U.S. medical oncologists feel about the current state of the advanced non-small cell lung cancer research and treatment landscape. #CancerResearch #NSCLC https://bit.ly/3vRDKBe
-
